language_icon
EN
HI

Epigral Share price

EPIGRAL

1240.4

1.00 (0.08%)
NSE
BSE
Last updated on 20 May, 2026 | 15:30 IST
Today's High

1250.00

Today's Low

1219.40

52 Week Low

807.00

52 Week High

2114.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Epigral Chart

Epigral Share Key Metrics

Volume
27242.00
Market Cap
5351.25 CR
LTQ@LTP
20@1240.40
ATP
1238.09
Var Margin
21.74 %
Circuit Range
991.6-1487.2
Delivery %
53.73 %
Value
3.37 CR
ASM/GSM
No
Market Lot
1

Summary

Epigral share price is ₹1240.4 as of 21 May, 2026. The stock Epigral intraday movement has stayed between ₹1219.40 and ₹1250.00, while on a 52-week basis,Epigral price 52 week high is ₹2114.00 & its 52 week low is ₹807.00.
In terms of trading activity, Epigral has recorded a volume of 27242 shares, The Epigral has a market cap of ₹43141338 CR. The stock’s Average Traded Price (ATP) stands at ₹1238.09, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 20 @ ₹1240.40.
Epigral operates within a circuit range of ₹991.60 – ₹1487.20, with a Value of ₹3.37 CR. The Delivery Percentage for the day is 53.73%. Additionally, Epigral currently falls under the No framework, and trades with a market lot size of 1.

Epigral Fundamentals

View More
P/E Ratio

16.09

P/B Ratio

2.4

Div. Yield

0.4

Sector P/E

42.25

Sector P/B

2.54

Sec. Div. Yield

0.44

Epigral Resistance and Support

Pivot 1230.17

Resistance

First Resistance

1260.24

Second Resistance

1281.07

Third Resistance

1311.14

Support

First Support

1209.34

Second Support

1179.27

Third Support

1158.44

Epigral Shareholding Pattern

View More
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

68.83%

Mutual Fund

4.9%

Insurance

0%

Foreign Institutional Investors

1.54%

Domestic Institutional Investors

0.02%

Retail

24.7%

Others

0.01%

Total Promoters
MAR '26
68.83%

Epigral Corporate Actions

DateAgenda
2026-05-02Audited Results & Final Dividend
2026-01-30Quarterly Results
2025-11-10Quarterly Results
2025-08-02Quarterly Results & Fund Raising
2025-05-05Audited Results & Final Dividend
2025-01-27Quarterly Results & Interim Dividend

Epigral News

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Epigral has scheduled its 19th Annual General Meeting (AGM) for June 8, 2026, via Video Conference. The board recommended a dividend of Rs.5.00 per equity share for FY26, and the record date for this dividend is fixed as June 1, 2026.
May 18 2026 18:05:00

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Epigral will participate in the Centrum's Nakshatra III Conference. The virtual event is scheduled for May 20, 2026, providing an opportunity to interact with investors and analysts.
May 18 2026 18:05:00

Epigral Limited

Epigral Limited's Board recommended a dividend of Rs.5 per equity share for the financial year 2025-26. The record date for determining eligible shareholders is June 01, 2026. This dividend is subject to shareholder approval at the upcoming 19th Annual General Meeting.
May 18 2026 18:05:00

Epigral Ltd - 543332 - Business Responsibility and Sustainability Reporting (BRSR)

Epigral has significantly advanced its ESG initiatives for FY26, including the establishment of an 18.34 MW wind-solar hybrid project and efforts to achieve carbon neutrality by 2030, targeting 50% renewable energy use by 2028.
May 15 2026 18:05:00

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Epigral is scheduled to hold a one-on-one meeting with Systematix Group on May 8, 2026, via video conferencing. The company confirmed that no unpublished price sensitive information will be discussed.
May 06 2026 18:05:00

Epigral Limited

Epigral Ltd submitted the transcript of its Q4 FY26 earnings conference call. The call discussed the company's record Q4 revenue of Rs.736 crore, strong EBITDA and PAT growth, and an optimistic outlook for FY27 volume growth and ongoing capex projects.
May 06 2026 13:05:00

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Epigral announced the availability of the audio recording for its conference call held on May 2, 2026. This call discussed the Q4 FY2026 financial results, providing investors access to detailed discussions.
May 03 2026 20:05:00

Epigral Limited

Epigral Limited's Board has recommended a final dividend of Rs. 5 per equity share for the financial year 2025-26. The record date and book closure details will be announced in due course.
May 02 2026 16:05:00

Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Epigral reported a record revenue of Rs 736 crore for Q4 FY26, marking a 17% YoY growth. Net profit for the quarter rose 109% sequentially to Rs 82 crore. The company also proposed a final dividend of Rs 5 per equity share for FY2026 and spent Rs 394 crore on capex in FY2026.
May 02 2026 16:05:00

Epigral Ltd - 543332 - Board Meeting Outcome for Approved Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And Year Ended On 31St March, 2026 And Recommended Final Dividend Of Rs. 5.00 (50%) Per Equity Share

Epigral's board approved Q4 FY26 cons. financial results, with revenue at ₹736.16 crore and net profit at ₹80.95 crore. The company also recommended a final dividend of ₹5.00 per equity share for FY26, to be paid as per the provisions of the Companies Act.
May 02 2026 15:05:00
Read More

About Epigral

NSE : 5382  
BSE : 543332  
ISIN : INE071N01016  

Epigral Management

NamePosition
Gaurang TrivediCompany Secretary & Compliance Officer
Maulik PatelChairman & Managing Director
View More

Epigral FAQs

The Buying Price of Epigral share is 1240.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Epigral stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Epigral, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Epigral shares is 16.09. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Epigral shares is 2.4. Useful to assess the stock's value relative to its book value.

To assess Epigral’s valuation compare Sector P/E, P/B which are 42.25 & 2.54 with sector averages, along with growth rates and financial metrics.

The Market Cap of Epigral is 5351.25 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Epigral share price is 2114.00 & 807.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Epigral belongs to the Chemicals sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost